This is a preview of subscription content, log in via an institution to check access.
References
Fanos V, Cataldi L. Antibacterial-induced nephrotoxicity in the newborn. Drug Saf 1999 Mar; 20(3): 245–67
Fanos V, Cataldi L. Aminoglycoside-induced nephrotoxicity in the newborn. In: Cataldi L, Fanos V, Simeoni U, editors. Neonatal nephrology in progress. Lecce: Agorà, 1996: 152–81
Saez-Llorens X, McCracken GH. Clinical pharmacology of antibacterial agents. In: Remington JS, Klein JO, editors. Infectious disease of the fetus, newborn and infants. Philadelphia: WB Saunders, 1995: 1287–336
Fanos V, Dall’Agnola A. Antibiotics in neonatal infections: a review. Drugs 1999 Sep; 58(3): 405–27
Fanos V, Kacet N, Mosconi G. A review of teicoplanin in the treatment of serious neonatal infections. Eur J Pediatr 1997; 156: 423–7
Dufful SB, Begg EJ. Vancomycin toxicity: what is the evidence for dose dependency? Adv Drug React Toxicol Rev 1994; 13(2): 103–14
Feketty FR. Safety of parenteral third generation cephalosporins. Am J Med 1990; 88 Suppl.: 38S–44S
Fried T. Acute interstitial nephritis: why do the kidneys fail? Postgrad Med 1993; 5: 105–20
Fanos V, Khoory BJ, Benini D, et al. Antibiotics nephropathy in the neonatal age [in Italian]. Doctor Pediatr 1997; 12(6): 5–14
Rights and permissions
About this article
Cite this article
Antibacterial-induced nephrotoxicity in the newborn can be avoided. Drugs Ther. Perspect 15, 10–12 (2000). https://doi.org/10.2165/00042310-200015070-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200015070-00004